Percutaneous transplantation of skeletal myoblast in the treatment of post-infarction injury

European Heart Journal, Supplement

Volumn 8, Issue H, 2006, Pages

  Siminiak, Tomasz ^a   Meliga, Emanuele ^b   Jerzykowska, Olga ^a   Serruys, Patrick W ^b  

^a POZNAN UNIVERSITY OF MEDICAL SCIENCES   (Poland)

^b ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

Catheter systems; Cell transplantation; Heart failure; Myoblasts

Indexed keywords

AUTOLOGOUS STEM CELL TRANSPLANTATION; CELL THERAPY; CELL TRANSPLANTATION; CELL VIABILITY; HEART CATHETER; HEART CONTRACTION; HEART FAILURE; HEART INFARCTION; HEART LEFT VENTRICLE; HEART MUSCLE CELL; HEART MUSCLE FIBROSIS; HEART MUSCLE INJURY; HEART MUSCLE REVASCULARIZATION; HEART PERFORMANCE; HUMAN; MULTIPOTENT STEM CELL; MUSCLE CELL; MYOBLAST; NONHUMAN; PRIORITY JOURNAL; REVIEW; SCAR;

EID: 33845990259     PISSN: 1520765X     EISSN: None     Source Type: Journal    
DOI: 10.1093/eurheartj/sul064     Document Type: Review

References (49)

1. Menasche P. Cell transplantation in myocardium. Ann Thorac Surg 2003;75(Suppl. 6):S20-S28.
2. Siminiak T, Kurpisz M. Myocardial replacement therapy. Circulation 2003;108:1167-1171.
3. Dimmeler S, Zeiher AM. Wanted! The best cell for cardiac regeneration. J Am Coll Cardiol 2004;44:464-466.
4. Dimmeler S, Zeiher AM, Schneider MD. Unchain my heart: the scientific foundations of cardiac repair. J Clin Invest 2005;115:572-583.
5. Laflamme MA, Murry CE. Regenerating the heart. Nat Biotechnol 2005;23:845-856.
6. Rafii S, Lyden D. Therapeutic stem and progenitor cell transplantation for organ vascularization and regeneration. Nat Med 2003;9:702- 712.
7. Edelberg JM, Xaymardan M, Rafii S, Hong MK. Adult cardiac stem cells - where do we go from here? Sci Aging Knowledge Environ 2003;2003:PE17.
8. Menasche P, Hagege AA, Vilquin JT, Desnos M, Abergel E, Pouzet B, Bel A, Sarateanu S, Scorsin M, Schwartz K, Bruneval P, Benbunan M, Marolleau JP, Duboc D. Autologous skeletal myoblast transplantation for severe postinfarction left ventricular dysfunction. J Am Coll Cardiol 2003;41:1078-1083.
9. Pagani FD, DerSimonian H, Zawadzka A, Wetzel K, Edge AS, Jacoby DB, Dinsmore JH, Wright S, Aretz TH, Eisen HJ, Aaronson KD. Autologous skeletal myoblasts transplanted to ischemia-damaged myocardium in humans. Histological analysis of cell survival and differentiation. J Am Coll Cardiol 2003;41:879-888.
10. Leobon B, Garcin I, Menasche P, Vilquin JT, Audinat E, Charpak S. Myoblasts transplanted into rat infarcted myocardium are functionally isolated from their host. Proc Natl Acad Sci USA 2003;100:7808-7811.
11. Ghostine S, Carrion C, Souza LC, Richard P, Bruneval P, Vilquin JT, Pouzet B, Schwartz K, Menasche P, Hagege AA. Long-term efficacy of myoblast transplantation on regional structure and function after myocardial infarction. Circulation 2002;106(Suppl. 1):I131-I136.
12. Reinecke H, Murry CE. Transmural replacement of myocardium after skeletal myoblast grafting into the heart. Too much of a good thing? Cardiovasc Pathol 2000;9:337-344.
13. Reinecke H, Minami E, Virag JI, Murry CE. Gene transfer of connexin43 into skeletal muscle. Hum Gene Ther 2004;15:627-636.
14. Beyer EC, Paul DL. J Cell Biol 1987;105:2621-2629.
15. Tolmachov O, Ma YL, Themis M, Patel P, Spohr H, Macleod KT, Ullrich ND, Kienast Y, Coutelle C, Peters NS. Overexpression of connexin 43 using a retroviral vector improves electrical coupling of skeletal myoblasts with cardiac myocytes in vitro. BMC Cardiovasc Disord 2006;6:25.
16. Rubart M, Soonpaa MH, Nakajima H, Field LJ. Spontaneous and evoked intracellular calcium transients in donor-derived myocytes following intracardiac myoblast transplantation. J Clin Invest 2004;114:775- 783.
17. Taylor DA, Atkins BZ, Hungspreugs P, Jones TR, Reedy MC, Hutcheson KA, Glower DD, Kraus WE. Regenerating functional myocardium: improved performance after skeletal myoblast transplantation. Nat Med 1998;4:929-933.
18. Hagege AA, Vilquin JT, Bruneval P, Menasche P. Regeneration of the myocardium: a new role in the treatment of ischaemic heart disease? Hypertension 2001;38:1413-1415.
19. Scorsin M, Hagege A, Vilquin JT, Fiszman M, Marotte F, Samuel JL, Rappaport L, Schwartz K, Menasche P. Comparison of the effects of fetal cardiomyocyte and skeletal myoblast transplantation on postinfarction left ventricular function. J Thorac Cardiovasc Surg 2000;119:1169-1175.
20. Ravens U. Electrophysiological properties of stem cells. Herz 2006;31:123-126.
21. Reinecke H, Zhang M, Bartosek T, Murry CE. Electromechanical coupling between skeletal and cardiac muscle. Implications for infarct repair. J Cell Biol 2000;149:731-740.
22. Tambara K, Sakakibara Y, Sakaguchi G, Lu F, Premaratne GU, Lin X, Nishimura K, Komeda M. Transplanted skeletal myoblasts can fully replace the infarcted myocardium when they survive in the host in large numbers. Circulation 2003;108(Suppl. 1):II259-II263.
23. Jain M, DerSimonian H, Brenner DA, Ngoy S, Teller P, Edge AS, Zawadzka A, Wetzel K, Sawyer DB, Colucci WS, Apstein CS, Liao R. Cell therapy attenuates deleterious ventricular remodeling and improves cardiac performance after myocardial infarction. Circulation 2001;103:1920-1927.
24. McConnell PI, del Rio CL, Jacoby DB, Pavlicova M, Kwiatkowski P, Zawadzka A, Dinsmore JH, Astra L, Wisel S, Michler RE. Correlation of autologous skeletal myoblast survival with changes in left ventricular remodeling in dilated ischaemic heart failure. J Thorac Cardiovasc Surg 2005;130:1001.
25. Zhang FB, Yang HT. Plasticity of bone marrow mesenchymal stem cells differentiating into cardiomyocytes and the potential of cardiac therapeutics. Sheng Li Ke Xue Jin Zhan 2006;37:199-204.
26. Xia JH, Xie AN, Zhang KL, Xu L, Zheng XY. The vascular endothelial growth factor expression and vascular regeneration in infarcted myocardium by skeletal muscle satellite cells. Chin Med J (Engl) 2006;119:117-121.
27. Hill E, Boontheekul T, Mooney DJ. Regulating activation of transplanted cells controls tissue regeneration. Proc Natl Acad Sci USA 2006;103:2494-2499.
28. Murtuza B, Suzuki K, Bou-Gharios G, Beauchamp JR, Smolenski RT, Partridge TA, Yacoub MH. Transplantation of skeletal myoblasts secreting an IL-1 inhibitor modulates adverse remodeling in infarcted murine myocardium. Proc Natl Acad Sci USA 2004;101:4216-4221.
29. Smits PC, van Geuns RJ, Poldermans D, Bountioukos M, Onderwater EE, Lee CH, Maat AP, Serruys PW. Catheter-based intramyocardial injection of autologous skeletal myoblasts as a primary treatment of ischaemic heart failure: clinical experience with six-month follow-up. J Am Coll Cardiol 2003;42:2063-2069.
30. Herreros J, Prosper F, Perez A, Gavira JJ, Garcia-Velloso MJ, Barba J, Sanchez PL, Canizo C, Rabago G, Marti-Climent JM, Hernandez M, Lopez-Holgado N, Gonzales-Santos JM, Martin-Luengo C, Alegria E. Autologous intramyocardial injection of cultured skeletal muscle-derived stem cells in patients with non-acute myocardial infarction. Eur Heart J 2003;24:2012-2020.
31. Siminiak T, Kalawski R, Fiszer D, Jerzykowska O, Rzezniczak J, Rozwadowska N, Kurpisz M. Autologous skeletal myoblast transplantation for the treatment of postinfarction myocardial injury: phase I clinical study with 12 months of follow-up. Am Heart J 2004;148:531-537.
32. Chachques JC, Herreros J, Trainini J, Juffe A, Rendal E, Prosper F, Genovese J. Autologous human serum for cell culture avoids the implantation of cardioverter-defibrillators in cellular cardiomyoplasty. Int J Cardiol 2004;95(Suppl. 1):S29-S33.
33. Siminiak T, Fiszer D, Jerzykowska O, Grygielska B, Rozwadowska N, Kalmucki P, Kurpisz M. Percutaneous trans-coronary-venous transplantation of autologous skeletal myoblasts in the treatment of postinfarction myocardial contractility impairment: the POZNAN trial. Eur Heart J 2005;26:1188-1195.
34. Menasche P, Hagege A, Scorsin M, Pouzet B, Desnos M, Duboc D, Schwartz K, Vilquin JT, Marolleau JP. Autologous skeletal myoblast transplantation for cardiac insufficiency. First clinical case. Arch Mal Coeur Vaiss 2001;94:180-182.
35. Siminiak T, Kalawski R, Kurpisz M. Myoblast transplantation in the treatment of postinfarction myocardial contractility impairment. Kardiol Pol 2002;56/2:131-137.
36. Dib N, McCarthy P, Campbell A, Yeager M, Pagani FD, Wright S, MacLellan WR, Fonarow G, Eisen HJ, Michler RE, Binkley P, Buchele D, Korn R, Ghazoul M, Dinsmore J, Opie SR, Diethrich E. Feasibility and safety of autologous myoblast transplantation in patients with ischaemic cardiomyopathy. Cell Transplant 2005;14:11-19.
37. Dib N, Michler RE, Pagani FD, Wright S, Kereiakes DJ, Lengerich R, Binkley P, Buchele D, Anand I, Swingen C, DiCarli MF, Thomas JD, Jaber WA, Opie SR, Campbell A, McCarthy P, Yeager M, Dilsizian V, Griffith BP, Korn R, Kreuger SK, Ghazoul M, MacLellan WR, Fonarow G, Eisen HJ, Dinsmore J, Diethrich E. Safety and feasibility of autologous myoblast transplantation in patients with ischaemic cardiomyopathy: four-year follow-up. Circulation 2005;112:1748-1755.
38. Muller-Ehmsen J, Whittaker P, Kloner RA, Dow JS, Sakoda T, Long TI, Laird PW, Kedes L. Survival and development of neonatal rat cardiomyocytes transplanted into adult myocardium. J Mol Cell Cardiol 2002;34:107-116.
39. Siminiak T, Fiszer D, Jerzykowska O, Grygielska B, Kalmucki P, Kurpisz M. Percutaneous autologous myoblast transplantation in the treatment of post-infarction myocardial contractility impairment-report on two cases. Kardiol Pol 2003;59:492-501.
40. Fuchs S, Satler LF, Kornowski R, Okubagzi P, Weisz G, Baffour R, Waksman R, Weissman NJ, Cerqueira M, Leon MB, Epstein SE. Catheter-based autologous bone marrow myocardial injection in no-option patients with advanced coronary artery disease: a feasibility study. J Am Coll Cardiol 2003;41:1721- 1724.
41. Perin EC, Dohmann HF, Borojevic R, Silva SA, Sousa AL, Mesquita CT, Rossi MI, Carvalho AC, Dutra HS, Dohmann HJ, Silva GV, Belem L, Vivacqua R, Rangel FO, Esporcatte R, Geng YJ, Vaughn WK, Assad JA, Mesquita ET, Willerson JT. Transendocardial, autologous bone marrow cell transplantation for severe, chronic ischaemic heart failure. Circulation 2003;107:2294-2302.
42. Sarmento-Leite R, Silva GV, Dohman HF, Rocha RM, Dohman HJ, de Mattos ND, Carvalho LA, Gottechall CA, Perin EC. Comparison of left ventricular electromechanical mapping and left ventricular angiography: defining practical standards for analysis of NOGA maps. Tex Heart Inst J 2003;30:19-26.
43. Siminiak T, Fiszer D, Jerzykowska O, Grygielska B, Rozwadowska N, Kalmucki P, Kurpisz M. Percutaneous transvenous transplantation of autologous myoblasts in the treatment of postinfarction heart failure: the POZNAN trial. Eur Heart J 2004;25(Suppl.):264.
44. Biagini E, Valgimigli M, Smits PC, Poldermans D, Schinkel AF, Rizzello V, Onderwater EE, Bountioukos M, Serruys PW. Stress and tissue Doppler echocardiographic evidence of effectiveness of myoblast transplantation in patients with ischaemic heart failure. Eur J Heart Fail 2006;8:641-648.
45. Steendijk P, Smits PC, Valgimigli M, van der Giessen WJ, Onderwater EE, Serruys PW. Intramyocardial injection of skeletal myoblasts: long-term follow-up with pressure-volume loops. Nat Clin Pract Cardiovasc Med 2006;3(Suppl. 1):S94-S100.
46. Smits PC, Nienaber C, Colombo A, Ince H, Carlino M, Theuns D, Biagini E, Valgimigli M, Onderwater E, Steendijk P, Peters NS, Goedhart D, Serruys PW. Myocardial repair by percutaneous cell transplantation of autologous skeletal myoblast as a stand alone procedure in post myocardial infarction chronic heart failure patients. EuroIntervention 2006;1:417-424.
47. Brasselet C, Morichetti MC, Messas E, Carrion C, Bissery A, Bruneval P, Vilquin JT, Lafont A, Hagege AA, Menasche P, Desnos M. Skeletal myoblast transplantation through a catheter-based coronary sinus approach: an effective means of improving function of infarcted myocardium. Eur Heart J 2005;26:1551-1556.
48. Abraham MR, Hare JM. Is skeletal myoblast transplantation proarrhythmic? The jury is still out. Heart Rhythm 2006;3:462-463.
49. Makkar RR, Lill M, Chen PS. Stem cell therapy for myocardial repair: is it arrhythmogenic? J Am Coll Cardiol 2003;42:2070-2072.